Killian Christopher Moore's Form 4/A amendment
AmendedEastman Chemical Co (EMN) · filed Jun 26, 2023
- Accession no.
- 0000915389-23-000128
- Filed
- Jun 26, 2023
- Trade date
- Feb 10, 2022
- Filing delay
- 501 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Feb 11, 2022
This filing lists 1 derivative transaction. It carries over 8 transactions from the original filing that it did not restate. Open-market sales total $1.81M. It was filed 501 days after the trade.
This amendment restates part of 0000899243-22-005835 (filed Feb 11, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Killian Christopher MooreCIK 0001866834 | Officer (SVP & CTO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Common Stock | MOption exerciseDisposed | −3,420 | $0.00 | $0 | 3,440 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000899243-22-005835 (filed Feb 11, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Common Stock | MOption exerciseAcquired | +6,478 | $104.21 | +$675,072.38 | 8,727 | Direct | |
| Feb 10, 2022 | Common Stock | SSaleDisposed | −6,478 | $122.75 | −$795,174.5 | 2,249 | Direct | |
| Feb 10, 2022 | Common Stock | MOption exerciseAcquired | +4,840 | $82.69 | +$400,219.6 | 7,089 | Direct | |
| Feb 10, 2022 | Common Stock | SSaleDisposed | −4,840 | $122.77 | −$594,206.8 | 2,249 | Direct | |
| Feb 10, 2022 | Common Stock | MOption exerciseAcquired | +3,420 | $72.92 | +$249,386.4 | 5,669 | Direct | |
| Feb 10, 2022 | Common Stock | SSaleDisposed | −3,420 | $122.73 | −$419,736.6 | 2,249 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Common Stock | MOption exerciseDisposed | −6,478 | $0.00 | $0 | 0 | Direct | |
| Feb 10, 2022 | Common Stock | MOption exerciseDisposed | −4,840 | $0.00 | $0 | 2,420 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Form 4 filed on February 11, 2022 incorrectly reported Item 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) as 6,869. The correct balance should be 3,440. This Amendment is filed to correct this balance only.